About NGIVD
NGIVD is a Healthcare company based in Gurugram (India) founded in 2015 by Ashok Jain, Srinivas Aluri Rao, Rajan T V, Pravin Kini, and Vivek Chandra. In-vitro diagnostic solutions for infectious diseases are developed. NGIVD has raised $1.85 million across 4 funding rounds from investors including Dipalee Ameet Desai, Aluri Rao Srinivasa and Rajan Viswanathan. Its chief executive, as recorded, is Vivek Chandra. Its Indian entity Nextgen In-Vitro Diagnostics Private Limited reported revenue of ₹1.87 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics.
Company details
NGIVD was founded in 2015 and is headquartered in Gurugram, India. In-vitro diagnostic solutions targeting infectious diseases are developed by the company within the healthcare sector. Products such as rapid card tests, ELISA kits, clinical chemistry kits, RT-PCR kits, nucleic acid purification kits, and reagents are provided for research and diagnostic applications. Operations emphasize tools for disease detection and analysis in laboratory settings.
- Headquarters Gurugram, India
- Founders Ashok Jain, Srinivas Aluri Rao, Rajan T V, Pravin Kini, Vivek Chandra
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ngivd.com
- Social LinkedIn X Facebook
- Legal Name Nextgen In-Vitro Diagnostics Private Limited
- Date of Incorporation 24 Apr, 2015
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.87 Cr
FY 2024 · +70% YoY
- Net Loss-₹5.85 Cr
FY 2024 · -313% margin
- EBITDA-₹5.09 Cr
FY 2024 · -272% margin
- Total Equity Funding$1.85M (USD)
in 4 rounds
- Latest Funding Round$498.53K (USD), Angel Round
Nov 2020
Associated legal entities of NGIVD
NGIVD operates through Nextgen In-Vitro Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nextgen In-Vitro Diagnostics Private Limited CIN U33110DL2015PTC279481 | Active | 24 Apr 2015 | New Delhi, Delhi | ₹1.9 Cr | 4 | View details |
Funding Insights of NGIVD
NGIVD has successfully raised a total of $1.85M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $498.53 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.85M
- Total Rounds 4
- Last Round Angel Round — $498,534
- First Round $868,325
(Jun 2017)
- Investors Count 12
All 4 funding rounds of NGIVD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $498,534 | Angel Round | – | Suresh Thakur | |
| Jun 2019 | $273,592 | Angel Round | – | Kunal Kaul, Puneet Gupta | |
| Sep 2018 | $206,772 | Angel Round | – | Rupinder Singh | |
| Jun 2017 | $868,325 | Angel Round | – | Rajan Viswanathan, Bharati Gupta |
12 investors in total: 0 institutional and 12 angel.
Investors in NGIVD
NGIVD has secured backing from 12 investors, including angel investors. Prominent investors backing the company include Dipalee Ameet Desai, Aluri Rao Srinivasa and Rajan Viswanathan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
DA Dipalee Ameet Desai | unknown_d3d3dc8064bc4d888 | |||
AR Aluri Rao Srinivasa | unknown_9d4dfe4ccfc34473a | |||
RV Rajan Viswanathan | unknown_5f328ceb0cee46829 | |||
KS K Sridharan | unknown_1e3b2e17c92746149 | |||
BG Bharati Gupta | unknown_e992dd99c62149fb8 | |||
ST Suresh Thakur | unknown_620a97b5a01d44d69 | |||
DG Dhruv Gupta | Co-founder of OrangeHealth, active angel investor in healthtech and consumer startups. | unknown_8abbc43120cf45faa | ||
VK Vijay Kumar | unknown_e109981d326f4a77b | |||
KK Kunal Kaul | unknown_8d5d52036a544d73a | |||
PG Puneet Gupta | Angel investor, ex-entrepreneur, focused on tech startups in India | unknown_ee347d2812b64d049 |
Investor details for NGIVD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Nextgen In-Vitro Diagnostics Private Limited (NGIVD)
Nextgen In-Vitro Diagnostics Private Limited is the primary company behind NGIVD. The board of Nextgen In-Vitro Diagnostics Private Limited currently have 4 directors; the longest-serving is Varun Chopra, appointed in 2015. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Varun Chopra DIN 01044311 | Director | 24 Apr 2015 | 11 yrs 5 mo | Nextgen In-Vitro Diagnostics Private Limited |
| Sushil Mehta DIN 01010831 | Director | 12 Oct 2016 | 10 yrs | Nextgen In-Vitro Diagnostics Private Limited |
| Ashok Kumar Jain DIN 05332592 | Director | 02 Mar 2020 | 6 yrs 7 mo | Nextgen In-Vitro Diagnostics Private Limited |
| Devashish Ohri DIN 03266071 | Managing Director | 12 Aug 2024 | 2 yrs 2 mo | Nextgen In-Vitro Diagnostics Private Limited |
People of NGIVD
5 people are tracked at NGIVD (5 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
Srinivas Aluri Rao | Co-Founder | Leadership |
Rajan T V | Co-Founder | Leadership |
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for NGIVD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NGIVD
Figures of Nextgen In-Vitro Diagnostics Private Limited, the primary company behind NGIVD, for FY 2024. Revenue was ₹1.87 Cr (+70% year on year). Net loss was -₹5.85 Cr (-313% margin). EBITDA was -₹5.09 Cr (-272% margin). Revenue has grown at a compounded annual rate of +59% over three years and +48% over five years.
- ₹1.87 CrRevenue · FY 2024 · +70% YoY
- -₹5.85 CrNet loss · -313% margin
- -₹5.09 CrEBITDA · -272% margin
- ₹2.04 CrPaid-up capital
- +59%Revenue CAGR, 3 years
- +48%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nextgen In-Vitro Diagnostics Private Limited are on its company page.
Detailed financial statements for NGIVD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NGIVD
3 dated milestones of NGIVD across 5 years, from founding to its latest funding, stage changes and deals.
- Founded NGIVD is founded.
- Funding First funding round of $868K.
- Funding Latest funding round, Angel Round, of $499K.
Web traffic of NGIVD
The website of NGIVD (ngivd.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 198.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NGIVD
NGIVD was founded in 2015 and raised its 1st funding round 2 years after it was founded.
NGIVD is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Vivek Chandra is the CEO of NGIVD, as recorded in our data. They have also founded this company.
NGIVD is a funded company, having raised a total of $1.85M across 4 funding rounds to date. The company's 1st funding round was a Angel Round of $868.33K, raised on Jun 2017.
The primary company behind NGIVD, Nextgen In-Vitro Diagnostics Private Limited, reported revenue of ₹1.87 Cr for FY 2024, up 70% year on year.
NGIVD was founded in 2015 and is headquartered in Gurugram, India. In-vitro diagnostic solutions targeting infectious diseases are developed by the company within the healthcare sector. Products such as rapid card tests, ELISA kits, clinical chemistry kits, RT-PCR kits, nucleic acid purification kits, and reagents are provided for research and diagnostic applications. Operations emphasize tools for disease detection and analysis in laboratory settings.
NGIVD has 12 investors. Key investors include Dipalee Ameet Desai, Aluri Rao Srinivasa, Rajan Viswanathan, K Sridharan, and Bharati Gupta.
NGIVD operates through Nextgen In-Vitro Diagnostics Private Limited.
The legal entities of NGIVD currently have 4 directors, including Varun Chopra, Sushil Mehta, Ashok Kumar Jain and others.